Grace MJ - Search Results

1

Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.

Brassard DL, Delorenzo MM, Cox S, Leaman DW, Sun Y, Ding W, Gavor S, Spond J, Goodsaid F, Bordens R, Grace MJ. Brassard DL, et al. Among authors: grace mj. J Interferon Cytokine Res. 2004 Aug;24(8):455-69. doi: 10.1089/1079990041689638. J Interferon Cytokine Res. 2004. PMID: 15320959

2

Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.

Grace MJ, Lee S, Bradshaw S, Chapman J, Spond J, Cox S, Delorenzo M, Brassard D, Wylie D, Cannon-Carlson S, Cullen C, Indelicato S, Voloch M, Bordens R. Grace MJ, et al. J Biol Chem. 2005 Feb 25;280(8):6327-36. doi: 10.1074/jbc.M412134200. Epub 2004 Dec 13. J Biol Chem. 2005. PMID: 15596441 Free article.

3

Pegylated IFNs for chronic hepatitis C: an update.

Grace MJ, Cutler DL, Bordens RW. Grace MJ, et al. Expert Opin Drug Deliv. 2005 Mar;2(2):219-26. doi: 10.1517/17425247.2.2.219. Expert Opin Drug Deliv. 2005. PMID: 16296749 Review.

4

Structural and biologic characterization of pegylated recombinant IFN-alpha2b.

Grace M, Youngster S, Gitlin G, Sydor W, Xie L, Westreich L, Jacobs S, Brassard D, Bausch J, Bordens R. Grace M, et al. J Interferon Cytokine Res. 2001 Dec;21(12):1103-15. doi: 10.1089/107999001317205240. J Interferon Cytokine Res. 2001. PMID: 11798469

5

Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications.

Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. Wang YS, et al. Adv Drug Deliv Rev. 2002 Jun 17;54(4):547-70. doi: 10.1016/s0169-409x(02)00027-3. Adv Drug Deliv Rev. 2002. PMID: 12052714 Review.

6

Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.

Youngster S, Wang YS, Grace M, Bausch J, Bordens R, Wyss DF. Youngster S, et al. Curr Pharm Des. 2002;8(24):2139-57. doi: 10.2174/1381612023393242. Curr Pharm Des. 2002. PMID: 12369859 Review.

7

Pegylated interferons for the treatment of chronic hepatitis C infection.

Luxon BA, Grace M, Brassard D, Bordens R. Luxon BA, et al. Clin Ther. 2002 Sep;24(9):1363-83. doi: 10.1016/s0149-2918(02)80042-x. Clin Ther. 2002. PMID: 12380630 Review.

8

Interferon-alpha as an immunotherapeutic protein.

Brassard DL, Grace MJ, Bordens RW. Brassard DL, et al. Among authors: grace mj. J Leukoc Biol. 2002 Apr;71(4):565-81. J Leukoc Biol. 2002. PMID: 11927642 Review.

9

Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.

Vyas K, Brassard DL, DeLorenzo MM, Sun Y, Grace MJ, Borden EC, Leaman DW. Vyas K, et al. Among authors: grace mj. J Immunother. 2003 May-Jun;26(3):202-11. doi: 10.1097/00002371-200305000-00004. J Immunother. 2003. PMID: 12806274

10

Biological characterization of pegylated interferons: a case study.

Xie L, Cullen C, Bradshaw S, DeLorenzo M, Grace MJ. Xie L, et al. Among authors: grace mj. Methods Mol Biol. 2005;308:319-35. doi: 10.1385/1-59259-922-2:319. Methods Mol Biol. 2005. PMID: 16082045 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters